Patent · US Active

Inhibitors of Flaviviridae viruses

US8884030B2 · kind B2 · utility

21Cited by
9References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 2013
Grant dateNov 11, 2014
Priority date—
Expiry dateAug 2, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are compounds of Formula I:and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.